🇺🇸 FDA
Patent

US 11185564

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

granted A61KA61K35/763A61K38/1748

Quick answer

US patent 11185564 (Compositions and methods for the treatment of wounds, disorders, and diseases of the skin) held by Krystal Biotech, Inc. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Krystal Biotech, Inc.
Grant date
Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/763, A61K38/1748, A61K38/39, A61K47/38